These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9103338)

  • 21. Levothyroxine bioequivalence.
    Katz MD; Scherger JE
    J Fam Pract; 1998 Feb; 46(2):108-9. PubMed ID: 9487307
    [No Abstract]   [Full Text] [Related]  

  • 22. Disclosure policies for gifts from industry to academic faculty.
    Bero LA
    JAMA; 1998 Apr; 279(13):1031-2. PubMed ID: 9533505
    [No Abstract]   [Full Text] [Related]  

  • 23. Interchangeability of levothyroxine preparations.
    DeGroot LJ
    Am J Med; 1996 Feb; 100(2):244-5; author reply 246-7. PubMed ID: 8629664
    [No Abstract]   [Full Text] [Related]  

  • 24. New questions regarding bioequivalence of levothyroxine preparations: a clinician's response.
    Green WL
    AAPS J; 2005 Mar; 7(1):E54-8. PubMed ID: 16146330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioequivalence of levothyroxine preparations: issues of science, publication, and advertising.
    Birnbaum R
    JAMA; 1997 Sep; 278(11):897-8; author reply 898-900. PubMed ID: 9302239
    [No Abstract]   [Full Text] [Related]  

  • 26. Bioequivalence of levothyroxine preparations: issues of science, publication, and advertising.
    Lankin KM
    JAMA; 1997 Sep; 278(11):897; author reply 898-900. PubMed ID: 9302238
    [No Abstract]   [Full Text] [Related]  

  • 27. Bioequivalence of levothyroxine preparations: issues of science, publication, and advertising.
    Donohoe M
    JAMA; 1997 Sep; 278(11):896-7; author reply 898-9. PubMed ID: 9302235
    [No Abstract]   [Full Text] [Related]  

  • 28. Levothyroxine sodium tablets: chemical equivalence and bioequivalence.
    Curry SH; Gums JG; Williams LL; Curry RW; Wolfson BB
    Drug Intell Clin Pharm; 1988; 22(7-8):589-91. PubMed ID: 3046889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioequivalence of levothyroxine preparations: issues of science, publication, and advertising.
    Brantigan CO
    JAMA; 1997 Sep; 278(11):897; author reply 898-9. PubMed ID: 9302236
    [No Abstract]   [Full Text] [Related]  

  • 30. Bioequivalence of thyroid preparations: the final word?
    Gibaldi M
    AAPS J; 2005; 7(1):E59-60. PubMed ID: 16493834
    [No Abstract]   [Full Text] [Related]  

  • 31. A duty to publish.
    Nat Med; 1998 Oct; 4(10):1089. PubMed ID: 9771720
    [No Abstract]   [Full Text] [Related]  

  • 32. Bioequivalence studies for levothyroxine.
    Bolton S
    AAPS J; 2005 Mar; 7(1):E47-53. PubMed ID: 16146349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Levothyroxine dosage and the limitations of current bioequivalence standards.
    Hennessey JV
    Nat Clin Pract Endocrinol Metab; 2006 Sep; 2(9):474-5. PubMed ID: 16957756
    [No Abstract]   [Full Text] [Related]  

  • 34. Morality play.
    Benet LZ
    Science; 1996 Sep; 273(5283):1782; author reply 1784-5. PubMed ID: 8815536
    [No Abstract]   [Full Text] [Related]  

  • 35. Levothyroxine and FDA bioequivalence ratings.
    Fox GN
    J Fam Pract; 2005 Feb; 54(2):179. PubMed ID: 15689298
    [No Abstract]   [Full Text] [Related]  

  • 36. In vivo comparison of levothyroxine preparations.
    Ramos-Gabatin A; Jacobson JM; Young RL
    JAMA; 1982 Jan; 247(2):203-5. PubMed ID: 7053460
    [No Abstract]   [Full Text] [Related]  

  • 37. Morality play.
    Eckert C
    Science; 1996 Sep; 273(5283):1784; author reply 1784-5. PubMed ID: 8815539
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparative bioavailability of two oral L-thyroxine formulations after multiple dose administration in patients with hypothyroidism and its relation with therapeutic endpoints and dissolution profiles.
    Vaisman M; Spina LD; Eksterman LF; dos Santos MJ; Lima JS; Volpato NM; da Silva RL; de Brito AP; Noël F
    Arzneimittelforschung; 2001; 51(3):246-52. PubMed ID: 11304941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Equivalence of various levothyroxine preparations.
    Fischer RG; Kibbe AH; Nicholas WC; Sbravati C; Read VH
    J Fam Pract; 1982 Mar; 14(3):591-3. PubMed ID: 7038029
    [No Abstract]   [Full Text] [Related]  

  • 40. Comment: therapeutic failure with levothyroxine brand interchange.
    Wolfson BB
    Ann Pharmacother; 1995 Oct; 29(10):1049-50. PubMed ID: 8845549
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.